Free Trial

Evolent Health (EVH) Stock Price, News & Analysis

Evolent Health logo
$9.63 -0.01 (-0.12%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$9.65 +0.03 (+0.27%)
As of 08/29/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Evolent Health Stock (NYSE:EVH)

Key Stats

Today's Range
$9.48
$9.84
50-Day Range
$8.71
$11.80
52-Week Range
$7.06
$32.35
Volume
1.37 million shs
Average Volume
3.80 million shs
Market Capitalization
$1.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.07
Consensus Rating
Buy

Company Overview

Evolent Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

EVH MarketRank™: 

Evolent Health scored higher than 25% of companies evaluated by MarketBeat, and ranked 558th out of 658 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Evolent Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Evolent Health has only been the subject of 3 research reports in the past 90 days.

  • Read more about Evolent Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Evolent Health are expected to decrease in the coming year, from $0.08 to ($0.29) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Evolent Health is -5.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Evolent Health is -5.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Evolent Health has a P/B Ratio of 1.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Evolent Health's valuation and earnings.
  • Percentage of Shares Shorted

    16.27% of the float of Evolent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Evolent Health has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Evolent Health has recently increased by 7.29%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Evolent Health does not currently pay a dividend.

  • Dividend Growth

    Evolent Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    16.27% of the float of Evolent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Evolent Health has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Evolent Health has recently increased by 7.29%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Evolent Health has a news sentiment score of 1.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.95 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Evolent Health this week, compared to 7 articles on an average week.
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVH Stock News Headlines

Contrasting Evolent Health (NYSE:EVH) & eGain (NASDAQ:EGAN)
How “Trump’s New Dollar” Could Impact Your Wealth
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."tc pixel
Evolent's Soft Q2 Results: Why I'm Holding Anyway
See More Headlines

EVH Stock Analysis - Frequently Asked Questions

Evolent Health's stock was trading at $11.25 on January 1st, 2025. Since then, EVH stock has decreased by 14.4% and is now trading at $9.6280.

Evolent Health, Inc (NYSE:EVH) announced its quarterly earnings data on Thursday, August, 7th. The technology company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by $0.20. The business's quarterly revenue was down 31.3% compared to the same quarter last year.
Read the conference call transcript
.

Evolent Health (EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Evolent Health's top institutional investors include Durable Capital Partners LP (5.47%), Engaged Capital LLC (4.99%), William Blair Investment Management LLC (3.68%) and Eventide Asset Management LLC (3.48%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Diane Holder, Emily Ann Rafferty, Cheryl Scott and Brendan B Springstubb.
View institutional ownership trends
.

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
8/07/2025
Today
8/30/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
INTERNET SOFTWARE
Sub-Industry
Business Services
Current Symbol
NYSE:EVH
CIK
1628908
Employees
4,500
Year Founded
N/A

Price Target and Rating

High Price Target
$35.00
Low Price Target
$12.00
Potential Upside/Downside
+87.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.61)
Trailing P/E Ratio
N/A
Forward P/E Ratio
120.35
P/E Growth
N/A
Net Income
-$61.62 million
Net Margins
-5.94%
Pretax Margin
-5.99%
Return on Equity
1.83%
Return on Assets
0.70%

Debt

Debt-to-Equity Ratio
0.72
Current Ratio
1.01
Quick Ratio
1.01

Sales & Book Value

Annual Sales
$2.20 billion
Price / Sales
0.52
Cash Flow
$1.52 per share
Price / Cash Flow
6.35
Book Value
$7.62 per share
Price / Book
1.26

Miscellaneous

Outstanding Shares
117,509,000
Free Float
115,864,000
Market Cap
$1.13 billion
Optionable
Optionable
Beta
0.82

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:EVH) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners